Transmembrane protein 39A (TMEM39A)

Transmembrane protein 39A (TMEM39A) is an evolutionarily conserved transmembrane protein with eight or nine predicted transmembrane domains, classified as a type III transmembrane protein predominantly localized to the endoplasmic reticulum and regulating multiple aspects of cellular physiology. TMEM39A coordinates intracellular organelle dynamics, notably lysosome positioning, ER stress responses, and autophagy, in part through its interactions with COPII complex components such as SEC23A and SEC24 and the dynein motor complex protein DYNC1I2. It is implicated in autoimmune disease risk, including multiple sclerosis and systemic lupus erythematosus, through its regulatory roles in immune cell function, lysosomal activity, collagen secretion, and type I interferon response. Emerging evidence suggests roles in tissue fibrosis and viral replication, but its molecular function and clinical utility as a drug target remain under active investigation. No approved drugs directly target TMEM39A as of the latest research, but its genetic variants are recognized risk markers for certain autoimmune conditions.

Other names

TMEM39ATransmembrane protein 39A39A (rare/short abbreviations)

Not established; potential targeting mechanisms could include modulation of autophagy pathways, ER-to-Golgi transport, or immune signaling, but no clinical/preclinical drugs or mechanisms established